Nomura Holdings
HQL

Nomura Holdings’s abrdn Life Sciences Investors HQL Stock Holding History

Nomura Holdings’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-200
Closed -$4K – 2137
2013
Q3 		$4K Buy
+200
New +$3.83K ﹤0.01% 2237

Other funds holding HQL

AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CFN
Cordasco Financial Network Naples, Florida $138M AUM 10.5% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
SFS
Shaker Financial Services Arlington, Virginia $319M AUM 3.9% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

Nomura Holdings's HQL Position: Q4 2013 in Review

Nomura Holdings sold out of abrdn Life Sciences Investors (HQL) in Q4 2013, closing a stake of 200 shares — an estimated $4K sold.

Nomura Holdings first reported a position in HQL in Q3 2013 and held it in 1 quarter. The position peaked at $4K in Q3 2013. 44 funds tracked by Wall St. Rank hold HQL as of Q4 2013.

  • Nomura Holdings reported no remaining abrdn Life Sciences Investors position as of Q4 2013 after selling out during the quarter.
  • Nomura Holdings sold 200 abrdn Life Sciences Investors shares in Q4 2013, an estimated $4K.
  • Nomura Holdings first reported a position in abrdn Life Sciences Investors in Q3 2013 and held it in 1 quarter.
  • Nomura Holdings's abrdn Life Sciences Investors position peaked at $4K in Q3 2013.
  • 44 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q4 2013.

Based on Nomura Holdings's 13F filing for Q4 2013, filed 14 Feb 2014.